CN111184791A - 一种治疗婴幼儿非感染性腹胀腹痛的中药软膏或凝胶 - Google Patents
一种治疗婴幼儿非感染性腹胀腹痛的中药软膏或凝胶 Download PDFInfo
- Publication number
- CN111184791A CN111184791A CN202010077276.5A CN202010077276A CN111184791A CN 111184791 A CN111184791 A CN 111184791A CN 202010077276 A CN202010077276 A CN 202010077276A CN 111184791 A CN111184791 A CN 111184791A
- Authority
- CN
- China
- Prior art keywords
- pain
- infants
- ointment
- gel
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000004998 Abdominal Pain Diseases 0.000 title claims abstract description 40
- 239000002674 ointment Substances 0.000 title claims abstract description 31
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 206010000060 Abdominal distension Diseases 0.000 title claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 17
- 241001078983 Tetradium ruticarpum Species 0.000 claims abstract description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 3
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 claims description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- 208000019790 abdominal distention Diseases 0.000 claims description 2
- 229940116229 borneol Drugs 0.000 claims description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 2
- 229940057995 liquid paraffin Drugs 0.000 claims description 2
- 229940041616 menthol Drugs 0.000 claims description 2
- 229940099259 vaseline Drugs 0.000 claims description 2
- 239000003623 enhancer Substances 0.000 claims 1
- 229940093499 ethyl acetate Drugs 0.000 claims 1
- 229960005150 glycerol Drugs 0.000 claims 1
- 229940100611 topical cream Drugs 0.000 claims 1
- 239000007788 liquid Substances 0.000 abstract description 5
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 208000002193 Pain Diseases 0.000 description 30
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 210000002784 stomach Anatomy 0.000 description 8
- 210000001015 abdomen Anatomy 0.000 description 7
- 230000002496 gastric effect Effects 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 208000002881 Colic Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 235000011054 acetic acid Nutrition 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 201000006549 dyspepsia Diseases 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 206010011469 Crying Diseases 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000002458 infectious effect Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229940083037 simethicone Drugs 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 208000005168 Intussusception Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010040925 Skin striae Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 206010016766 flatulence Diseases 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 230000000474 nursing effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000173529 Aconitum napellus Species 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 2
- 206010010947 Coordination abnormal Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000792859 Enema Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010021531 Impetigo Diseases 0.000 description 2
- 208000030852 Parasitic disease Diseases 0.000 description 2
- 208000008469 Peptic Ulcer Diseases 0.000 description 2
- ACVGWSKVRYFWRP-UHFFFAOYSA-N Rutecarpine Chemical compound C1=CC=C2C(=O)N(CCC=3C4=CC=CC=C4NC=33)C3=NC2=C1 ACVGWSKVRYFWRP-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940023019 aconite Drugs 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007920 enema Substances 0.000 description 2
- 229940095399 enema Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 208000016290 incoordination Diseases 0.000 description 2
- 230000000366 juvenile effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 208000010453 mesenteric lymphadenitis Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000011906 peptic ulcer disease Diseases 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- 229960000776 sodium tetradecyl sulfate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 2
- 210000003954 umbilical cord Anatomy 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 239000003871 white petrolatum Substances 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- TXDUTHBFYKGSAH-SFHVURJKSA-N Evodiamine Chemical compound C1=CC=C2N(C)[C@@H]3C(NC=4C5=CC=CC=4)=C5CCN3C(=O)C2=C1 TXDUTHBFYKGSAH-SFHVURJKSA-N 0.000 description 1
- HMXRXBIGGYUEAX-SFHVURJKSA-N Evodiamine Natural products CN1[C@H]2N(CCc3[nH]c4ccccc4c23)C(=O)c5ccccc15 HMXRXBIGGYUEAX-SFHVURJKSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 241000112528 Ligusticum striatum Species 0.000 description 1
- 241001673966 Magnolia officinalis Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- BCPAKGGXGLGKIO-UHFFFAOYSA-N Pseudorutaecarpin Natural products C1=CC=C2C(=O)N(CCC3=C4C5=CC=CC=C5N3)C4=NC2=C1 BCPAKGGXGLGKIO-UHFFFAOYSA-N 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- CDXSJGDDABYYJV-UHFFFAOYSA-N acetic acid;ethanol Chemical compound CCO.CC(O)=O CDXSJGDDABYYJV-UHFFFAOYSA-N 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960002152 chlorhexidine acetate Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 201000009243 chronic laryngitis Diseases 0.000 description 1
- 210000004913 chyme Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229960001275 dimeticone Drugs 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- -1 flavone alkaloid Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/754—Evodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中医中药技术领域,提供了一种组方简单的用于治疗婴幼儿腹胀腹痛的软膏或凝胶制剂,其主要特征在于该方剂仅含吴茱萸一味中药成分并以软膏或凝胶等液体或半固体形式存在,可直接涂抹而无需敷贴和遮盖。
Description
技术领域
本发明涉及中医中药技术领域,提供了一种组方简单的用于治疗婴幼儿腹胀腹痛的软膏或凝胶制剂。
背景技术
腹胀腹痛是婴幼儿(28天以下为新生儿,3周岁以下为婴儿,3至6周岁为幼儿)常见病症之一,原因包括细菌感染、病毒感染、寄生虫感染及消化性溃疡、肠套叠、肠系膜淋巴结炎、消化不良所致肠胀气、肠痉挛等。其中,非感染性腹胀痛中,消化性溃疡、肠套叠、肠系膜淋巴结炎等严重情况相对少见而消化不良所致胃肠胀气、胃肠痉挛(胃肠绞痛)较多见,中医常谓之“积滞”,基本相当于西医功能型腹痛之范围。积滞于两三岁内婴儿甚为常见,尤其两三月龄内新生儿则更属高发。有研究显示,约30%的婴儿曾有肠绞痛现象,甚至有学者认为几乎所有婴儿都会出现胃肠胀痛现象,唯轻重程度不同而已。婴儿胃肠胀痛一般始于一至四周,四到六周达到高峰,通常四至六个月会随着胃肠功能之发育完善而自行改善。胃肠胀痛较剧(俗称肠绞痛)婴儿会出现突然性大声哭叫,可持续数小时,常每日几乎定时发作,也可日内多次阵发性发作,哭时面部通红,口周苍白,腹部鼓胀而紧张,双腿向上蜷曲,双足发凉,双手紧握,抱哄喂奶皆不能缓解,终以哭得力竭、排气或排便而止,每周发作多次甚至每日几乎同一时间且多为傍晚发生,其间对父母亲人等产生极大煎熬。发生原因包括哺喂姿势不对,婴儿吸乳时吞入大量空气、哭吵时吸入较多空气形成气泡在胃肠内移动致腹痛、喂奶过饱使胃过度扩张引起不适、婴儿胃肠神经及功能发育不够成熟,消化系统各段运动/蠕动不受神经很好的协调控制,肠内气体不能顺利排出等。处理方法包括控制哺乳姿势和哺乳量、哺乳后竖抱并充分拍嗝、每日及发作时腹部按摩、飞机抱、肛门应用小儿开塞露和口服西甲硅油通便排气等。然经常出现诸多方法均不奏效以及开塞露应用不便、口服二甲硅油影响婴幼儿营养吸收等问题。传统中医中药也有一些治疗婴幼儿肠绞痛的口腹药方,然低龄婴幼儿服用困难而极不配合,依从性差。一些外用贴剂则存在主要解决腹泻而非腹痛或包覆婴儿尚未彻底愈合之脐带残端易引起感染、贴用部位易发生过敏和湿疹、敷贴不稳易掉落、粘贴过紧则揭帖疼痛等问题。故此,研发更安全适用且无需贴敷之新药物新剂型实属必要。
发明内容
本发明提供了一种专用于治疗婴幼儿尤其是6个月以内婴儿非感染性腹痛的中药软膏或凝胶制剂及其制备方法,其主要特征在于该方剂仅含吴茱萸一味中药成分并以软膏或凝胶等液体或半固体形式存在,可直接涂抹而免于遮盖或敷贴。经查,国内外目前均尚无以吴茱萸单一药味组方并以软膏或凝胶等液体和半固体形式存在的专用于婴幼儿非感染性腹痛的治疗药物,也无类似专利申请与授权。
被西医称认为是消化不良所致的一组胃肠胀气和痉挛绞痛等症状,中医谓之积滞。积滞之名,首见于《婴童百问》,是因乳食内积、脾胃受损而致食停中焦、积而不花、气滞不行所形成的一种胃肠疾患。本病一年四季皆可发生,各年龄组小儿皆可发病,但以婴幼儿多见,一般预后良好,但少数患者积久不化,迁延失治,脾胃功能严重受损,影响小儿营养及生长发育。《古今医统﹒腹痛》载:“小儿腹痛之病,诚为急切。凡初生二三月及一周之内,多有腹痛之患。无故啼哭不已,或夜间啼哭之甚,多是腹痛之故,大都不外寒热二因”。《小儿卫生总徽论方》载“小儿心腹痛者,由脏腑虚而寒冷之气所干,邪气与脏器相搏,上下冲击,上则为心痛,下则为腹痛,上下俱作,心腹皆痛。更有一证,发则腹中撮痛,干啼无泪,腰曲背弓,上唇干,额上有汗,此名盘肠内钓之痛,亦由冷气入脏所为也”。《小儿药证直诀﹒脉证治法》将腹痛分为积痛、虫痛、胃冷虚之证。明代《证治准绳﹒幼科﹒腹痛》中归纳前人经验,列有寒痛、积痛、虫痛、锁肚痛、盘肠内钓痛、症瘕痛等。本发明分析认为,《证治准绳﹒幼科﹒腹痛》中所载虫痛,应与现代医学之寄生虫感染相关,锁肚痛与肠梗阻等类似,盘肠内钓痛则与肠套叠类似,本发明所要解决的非感染性腹痛则与积痛、寒痛相关,多因乳食不节而内积不化加之脾胃虚寒以致气滞不行所致。尽管历代医家对婴幼儿非感染性腹胀腹痛多有表述并载有多方,然因制剂技术之时代局限,却多以内服方剂为主,鲜见外用经方,低龄婴幼儿内服药物多有不便且依从性甚差。目前市面虽有用于小儿腹痛腹泻之外用贴剂销售,然包覆婴儿尚未彻底愈合之脐带残端易引起感染,且贴用部位易发生过敏和湿疹,并有敷贴不稳易掉落、粘贴过紧则揭帖疼痛等问题。化学药物西甲硅油乳剂是二甲硅油和二氧化硅组成的复合物,为一表面活性剂,常被西医用于解决婴幼儿胃肠胀痛问题,其作用机理为改变消化道中存在于食糜和粘液内的气泡之表面张力以使之分解,释放出的气体被肠壁吸收并通过肠蠕动排出。然西甲硅油属于非水溶性矿物油脂,不能被胃肠道吸收,也不能被快速完全排出而黏附于胃肠壁,影响小儿胃肠对营养素的消化和吸收,这对快速成长期的婴幼儿多有不利。本发明以单味传统中药吴茱萸为基础并以现代制剂辅料与技术将之制备为使用简便、无需内服也无需敷贴的外用软膏(乳膏)或凝胶,解决了上述一应不利。
吴茱萸,中药,按中国药典2015版载,别名吴萸、茶辣、辣子、臭辣子、吴椒、臭泡子等,为芸香科植物吴茱萸、石虎或疏毛吴茱萸的干燥近成熟果实。味辛,苦,温,有小毒。归肝、脾、胃、肾经。功能主治为:散寒止痛,降逆止呕,助阳止泻;用于厥阴头痛,寒疝腹痛,寒湿脚气,经行腹痛,脘腹胀痛,呕吐吞酸,五更泄泻,外治口疮,高血压。《本经》:主温中下气,止痛,咳逆寒热,除湿血痹,逐风邪,开腠理。《别录》:主痰冷,腹内绞痛,诸冷实不消,中恶,心腹痛,逆气,利五脏。《药性论》:主心腹疾,积冷,心下结气,疰心痛;治霍乱转筋,胃中冷气,吐泻腹痛不可胜忍者;疗遍身顽痹,冷食不消,利大肠拥气。《日华子本草》:"健脾通关节。治腹痛,肾气,脚气,水肿,下产后余血。《神农本草经》:主温中下气,止痛,咳逆寒热,除湿血痹,逐风邪,开腠理。《神农本草经》:主温中下气,止痛,咳逆寒热,除湿血痹,逐风邪,开腠理。可见,古今各家都认为吴茱萸具温中止痛、下气制逆之功。然各家用于腹脘胀痛时,均以口服为主,如《太平圣惠方》卷四吴茱萸散,功效:温中散寒,主治小肠虚寒,小腹刺痛,或绕脐结痛,身出冷汗。组方:吴茱萸7.5克(汤浸七遍,焙干微炒)厚朴15克(去粗皮,涂生姜汁,炙令香熟)川芎30克干姜15克(炮裂,锉)甘草15克(炙微赤,锉)附子22.5克(炮裂,去皮、脐);用法:上药捣为粗散。每服9克,以水300毫升,煎至180毫升,去滓,不计时候,稍热服。再如《本草纲目﹒果部﹒吴茱萸》:心腹冷痛,用吴茱萸五合,加酒三升煮开,分三次服。以外用形式存在的一些方剂也不以小儿腹痛为治疗目的,如《普济方》(公元1406年)卷四十六头门首风附论治头风沐头方(出肘后方)用吴茱萸二升,水五升,煮取三升,以绵蘸拭发根良。再如《中医皮肤病学简编》 (程运乾 / 陕西人民出版社 / 1979 )以吴茱萸软膏治黄水疮(感染性脓包疮)。又如《手部疗法治百病》(程爵棠/ 2005)以吴茱萸等治疗慢性咽炎、喉炎,其组方为吴茱萸30克,生附子6克,麝香0.3克;上药共研极细末,用米醋调和成软膏,贮瓶;每次取药膏20克,外敷于双侧劳宫穴。近年一些与吴茱萸有关的专利申请,也均为多味药物之复方组合物,剂型以贴剂常见,用途包括妇女产后宫寒腹痛并消化不良等。未查见有以吴茱萸单一药味为方同时以婴幼儿腹胀痛为治疗目的并以软膏或凝胶等液体或半固体形式存在的类似制剂和专利申请,本发明在该等领域属于创举。
4、经分析与研究,吴茱萸原药及提取物具相似作用,唯使用剂量不同。故既可将原药充分粉碎后辅之以液体石蜡或(和)凡士林、甘油、硅酮、羊毛脂、二甲硅油、蜂蜡、醋酸、硬脂酸、蓖麻油、卡波姆、透明质酸钠等赋形剂及醋酸氯己定等防腐剂直接制作成软膏(乳膏)或凝胶,也可以将原药以乙醇或乙酸乙酯、甲醇、丙酮等溶剂提取后浓缩精制再与赋形剂和防腐剂混合制作成软膏(乳膏)或凝胶。从环保及经济效益角度出发,以原药充分粉碎后与直接与赋形剂并防腐剂混合制作软膏(乳膏)或凝胶为优选。为了促进透皮吸收,制剂中还可以加入不超过5%的氮酮或薄荷脑、冰片、十四烷基硫酸钠等促透皮吸收剂(十四烷基硫酸钠既具有促透皮作用,尚具有一定防腐抗菌作用)。据分析和研究,吴茱萸中包含挥发油及黄酮并生物碱等多类活性物质,不同种类成分具有不同功效故也有不同用途,其制法自然也有不同。多类活性组分中,起解痉止痛的成分分析应主要是生物碱类物质,挥发油类应有协助排气止逆之功,两相协同则相得益彰,故用于治疗婴幼儿腹胀腹痛可有较好效果。以原药粉碎后直接制剂时,宜以乙酸或稀盐酸并甘油、乙酸乙醇等有机溶剂作为分散剂和赋形剂,盖因乙酸或稀盐酸可与碱性物质生成易溶于水之盐以加大透皮吸收能力,唯盐酸为强酸,用量过多有一定腐蚀性,须依据药量仔细计算用量。以提取物制剂时,因生物碱类物质多不溶于水,本发明摒弃传统水提取工艺,改用75%乙醇提取,乙醇使用量设计为5倍和 l0倍、15倍量三组,均分别室温搅拌提取1.0小时、2.0小时和3小时,每组提取2次后混合提取液并过滤,滤液以高效液相色谱法测吴茱萸碱及吴茱萸次碱含量并加和计算总收得率,结果表明,10倍量提取2小时为最优选方法,总生物碱收得率约占药材量0.53%。色谱柱为Intersil C18柱(250nm×4.6nm,5μm),流动相为乙腈-水(55:45),流速1ml/min,波长225nm),柱温35℃。各组收得情况如下表:
附图说明
图1为吴茱萸原药经粉碎后的极细粉;图2为吴茱萸细粉与醋酸及白凡士林、甘油混合调匀所得软膏;图3为茱萸软膏装入软膏管所得成品。
5、实施例1(非限制性):取吴茱萸100克,以20000转/min转速将之粉碎为极细粉(如图1;过粗难以直接成形)备用,另取醋酸(36%—38%)20毫升并白凡士林30毫升、甘油150毫升混匀后加入吴茱萸细粉搅拌,得图2所示之浅棕色软膏,将之装入图3所示之软胶管即得。
6、实施例2(非限制性):取吴茱萸100克,以5000转/min略粉碎,加入1000ml浓度为75%之乙醇中,置室温搅拌2h,滤出滤液备用;滤渣再加入1000ml浓度为75%之乙醇,仍置室温搅拌2h,滤出滤液,弃去滤渣;合并两次滤液,蒸馏浓缩至密度约1.05之浸膏,加入100倍量之透明质酸钠凝胶中充分搅拌混匀,装入软胶管,即得。
7、取上述吴茱萸细粉直接制剂所得之软膏约10g,涂敷于发明人肚脐并以纱布固定,24小时后揭除,期间及其后无任何感觉;后,取该软膏约1.0(相当于成人剂量之1/10),涂敷于发明人约2月龄女婴,4剂后持续月余之每晚8时左右腹痛啼哭症状消失,无任何不适。其后周边亲友婴幼儿有如此者,告以约1g吴茱萸研碎后以适量食醋调和敷脐(避开肚脐残端)并以纱布遮盖,12h后移除,再12h后重复施用,计约10例,每试不爽,快者一剂而愈,慢者三四剂而愈,并无复发,亦无不适。
8、常规用法与用量:取上剂适量(约0.5—1.0g),以手指均匀涂抹于患儿肚脐并四周,每12小时施用1次。
Claims (4)
1.一种治疗婴幼儿非感染性腹胀腹痛的外用乳膏(软膏)或凝胶,其主要特征在于组方仅吴茱萸一味中药(但不排除冰片、薄荷脑、氮酮等促透皮吸收剂及凡士林、液体石蜡、甘油、乙酸乙酯、卡波姆等赋形剂存在)。
2.如权利要求1所述之制剂所用吴茱萸可以原药(包括生药和炮制药)粉末或提取物入药。
3.如权利要求1所述之药物限用于6周岁以下婴幼儿之非感染性腹胀腹痛。
4.如权利要求1所述之制剂中冰片或薄荷脑、氮酮等以促透皮剂存在时,其含量不超过成药之5%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010077276.5A CN111184791A (zh) | 2020-01-26 | 2020-01-26 | 一种治疗婴幼儿非感染性腹胀腹痛的中药软膏或凝胶 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010077276.5A CN111184791A (zh) | 2020-01-26 | 2020-01-26 | 一种治疗婴幼儿非感染性腹胀腹痛的中药软膏或凝胶 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111184791A true CN111184791A (zh) | 2020-05-22 |
Family
ID=70686049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010077276.5A Pending CN111184791A (zh) | 2020-01-26 | 2020-01-26 | 一种治疗婴幼儿非感染性腹胀腹痛的中药软膏或凝胶 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111184791A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI828208B (zh) * | 2022-06-24 | 2024-01-01 | 黃彥維 | 含吳茱萸之外用藥膏及其製備方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110339260A (zh) * | 2019-08-12 | 2019-10-18 | 含山县中医医院 | 一种寒性小儿腹痛肚脐贴及其制备方法 |
-
2020
- 2020-01-26 CN CN202010077276.5A patent/CN111184791A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110339260A (zh) * | 2019-08-12 | 2019-10-18 | 含山县中医医院 | 一种寒性小儿腹痛肚脐贴及其制备方法 |
Non-Patent Citations (2)
Title |
---|
管淑兰;: "吴茱萸外用治疗虚寒性胃痛效佳" * |
胡烈;: "吴茱萸的外用疗法" * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI828208B (zh) * | 2022-06-24 | 2024-01-01 | 黃彥維 | 含吳茱萸之外用藥膏及其製備方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103432559A (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN111184791A (zh) | 一种治疗婴幼儿非感染性腹胀腹痛的中药软膏或凝胶 | |
CN103705791B (zh) | 一种用于临床麻醉的药物及制备方法 | |
CN102872368B (zh) | 一种用于泻火解毒的中药贴敷制剂 | |
CN104958581A (zh) | 一种用于治疗毛囊炎的中药制剂及制备方法 | |
CN114366776B (zh) | 一种治疗小儿口疮的中药制剂及其制备方法 | |
CN103893613A (zh) | 一种治疗口腔溃疡的药物及制备方法 | |
CN107970388A (zh) | 一种用于治疗咽炎的药物组合物、制剂及其制备方法、应用 | |
CN103212030B (zh) | 一种治疗肝郁型乳腺增生的中药及制备方法 | |
CN103432466B (zh) | 治疗女性盆腔炎的中药组合物及其制备方法 | |
TW201332563A (zh) | 一種用以治療癌末便秘症狀的中草藥製劑及方法 | |
CN102106999A (zh) | 一种治疗中风病后吞咽困难的中药复方制剂及其制备方法 | |
CN101439150B (zh) | 一种治疗肠炎的中药组合物 | |
CN114712466B (zh) | 一种具有减肥养颜功效的药物及其制备方法 | |
CN104353043A (zh) | 一种治疗五更泻的中药组合物及其制备方法 | |
CN117462642B (zh) | 一种治疗腹泻的中药组合物及其制备方法和用途 | |
CN116115681B (zh) | 一种用于制备治疗扁桃体发炎药物的配方及方法 | |
CN105688171B (zh) | 一种雏鸡用饲料添加剂及其制备方法 | |
CN103520644B (zh) | 用于治疗痰瘀型高脂血症的中药组合物及其制备方法 | |
CN103211988B (zh) | 治疗猪传染性胃肠炎症的药物组合 | |
CN111529658B (zh) | 一种治疗轮状病毒性肠炎的膏剂及制备方法 | |
CN105963423A (zh) | 一种清咽润喉软胶囊制剂及其制备方法 | |
CN105250431A (zh) | 一种治疗胃肠炎的中药制剂及制备方法 | |
CN105031389A (zh) | 一种配合放疗法抑制恶性肿瘤繁殖的中药片剂及制法 | |
CN103735911B (zh) | 一种治疗风疹的药物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200522 |